highperformr logo

Acer Therapeutics Inc.'s Overview

Total employees13
HeadquartersNewton
Founded2013

Acer Therapeutics Inc. was a pharmaceutical company dedicated to the acquisition, development, and commercialization of therapies for serious rare and ultra-rare diseases with significant unmet medical needs. Their pipeline included candidates for conditions such as Urea Cycle Disorders (UCDs), Maple Syrup Urine Disease (MSUD), and Vascular Ehlers-Danlos Syndrome (vEDS). In 2023, Acer Therapeutics was acquired by Zevra Therapeutics, Inc. Acer's key programs, such as OLPRUVA™ (sodium phenylbutyrate) for UCDs, are now part of Zevra's portfolio.

Where is Acer Therapeutics Inc.'s Headquarters?

HQ Function

Served as the primary corporate office for executive leadership, research and development program management, clinical operations oversight, and administrative functions for Acer Therapeutics before its acquisition.

Notable Features:

The headquarters was likely a modern office space within a business center, designed to facilitate collaboration and manage pharmaceutical development programs. Specific architectural highlights are not widely publicized.

Work Culture:

As a company focused on rare diseases, the work culture likely emphasized scientific rigor, patient-centricity, innovation, and a sense of urgency in addressing unmet medical needs. Collaboration among scientific, clinical, and regulatory teams would have been crucial.

HQ Significance:

The Newton headquarters was central to Acer's strategic decision-making, clinical trial management, and efforts to bring new therapies for rare diseases to market. It represented the core of their operational and scientific endeavors.

Values Reflected in HQ: The choice of a professional office space likely reflected values of efficiency, professionalism, and a focus on the core business of pharmaceutical development.

Location:

Prior to its acquisition by Zevra Therapeutics, Acer Therapeutics Inc. was primarily focused on the United States market for its drug development and commercialization activities. Clinical trials for its product candidates may have involved sites in multiple countries to ensure diverse patient populations and meet regulatory requirements, but its core operational presence and commercial strategy were U.S.-centric.

Street Address:

One Gateway Center, Suite 351

City:

Newton

State/Province:

MA

Country:

USA

Acer Therapeutics Inc.'s Global Presence

Buying Intent Signals for Acer Therapeutics Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Acer Therapeutics Inc.

As of April 2025, Acer Therapeutics Inc.' leadership includes:

Chris Schelling - Co-founder, Chief Executive Officer and Director
Harry S. Palmin - Chief Financial Officer and Treasurer
William T. Andrews - Chief Medical Officer
Don Joseph - Chief Legal Officer and Corporate Secretary

Investors of Acer Therapeutics Inc.

Acer Therapeutics Inc. has been backed by several prominent investors over the years, including:

Zevra Therapeutics, Inc. (Acquirer)
Marathon Asset Management (Pre-acquisition)
Armistice Capital (Pre-acquisition)
Lincoln Park Capital Fund (Pre-acquisition)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits4

The most significant executive changes at Acer Therapeutics Inc. in the last 12-18 months are related to its acquisition by Zevra Therapeutics in mid-2023. This led to the transition or departure of Acer's standalone executive team as operations were integrated.

Departures

Chris Schelling, Departed as CEO following the acquisition by Zevra Therapeutics.
Harry S. Palmin, Departed as CFO following the acquisition by Zevra Therapeutics.
William T. Andrews, Departed as CMO following the acquisition by Zevra Therapeutics.
Don Joseph, Departed as CLO following the acquisition by Zevra Therapeutics.

Technology (Tech Stack) used by Acer Therapeutics Inc.

Discover the tools Acer Therapeutics Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Acer Therapeutics Inc. Email Formats and Examples

Prior to its acquisition, Acer Therapeutics Inc. likely used common corporate email formats. A common pattern for companies of its size is [first_initial][last]@[companydomain].com or [first].[last]@[companydomain].com.

[first_initial][last]@acertherapeutics.com

Format

jsmith@acertherapeutics.com

Example

75%

Success rate

News and media

Zevra TherapeuticsAugust 21, 2023

Zevra Therapeutics Completes Acquisition of Acer Therapeutics Inc.

Zevra Therapeutics, Inc. announced the completion of its acquisition of Acer Therapeutics Inc. This acquisition brings Acer's lead product candidate, OLPRUVA™ (sodium phenylbutyrate), for Urea Cycle Disorders (UCDs) into Zevra's portfolio....more

GlobeNewswireMay 31, 2023

Zevra Therapeutics to Acquire Acer Therapeutics

Zevra Therapeutics and Acer Therapeutics announced they entered into a definitive merger agreement under which Zevra would acquire Acer. The deal aimed to strengthen Zevra's rare disease portfolio....more

Acer Therapeutics Inc.January 27, 2023

Acer Therapeutics Announces FDA Approval of OLPRUVA™ (sodium phenylbutyrate) for Oral Suspension for the Treatment of Patients with Urea Cycle Disorders (UCDs)

Acer Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved OLPRUVA™ for the treatment of certain UCDs involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS)....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Acer Therapeutics Inc., are just a search away.